Mature results of MM-011: A phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma

Aleksandr Lazaryan, Mohamad A. Hussein, Frederic J. Reu, Beth Faiman, Becky Habecker, Mary Ann Karam, Janice Reed, Kimberly Hamilton, Joel Waksman, Kellie Bruening, Gordan Srkalovic, Steven Andresen, Matthew Kalaycio, John W. Sweetenham, Ronald Sobecks, Robert Dean, Robert Knight, Jerome B. Zeldis, Rachid Baz

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Sort by
Weight
Alphabetically

Mature results of MM-011: A phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma

Fingerprint

Medicine & Life Sciences